IN BRIEF: Celadon receives GBP492,000 in loan, tax credit payments

Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based ...

Alliance News 12 February, 2025 | 9:51AM
Email Form Facebook Twitter LinkedIn RSS

Celadon Pharmaceuticals PLC - London-based pharmaceutical company, focused on cannabis-based medicines - Says it has received the final GBP103,000 from its GBP1.0 million draw down request under its committed credit facility. Says it has also received a GBP389,000 tax credit from a 2022 research & development claim. The company says it will continue to explore "further capital opportunities".

Current stock price: 20.51 pence, up 14% in London on Wednesday morning

12-month change: down 82%

By Michael Hennessey, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2025 Alliance News Ltd. All Rights Reserved.

Email Form Facebook Twitter LinkedIn RSS

Securities Mentioned in Article

Security Name Price Change (%) Morningstar
Rating
Celadon Pharmaceuticals PLC 21.55 GBX 19.72 -

About Author

Alliance News

Alliance News provides Morningstar with continuously updating coverage of news affecting listed companies.

© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures